We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
+12.04%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.16B
AUM Growth
+$114M
(+11%)
Cap. Flow
-$2.42M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
74.62%
Holding
64
New
–
Increased
1
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$79.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.87M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$380K |
| 3 |
Elevance Health
ELV
|
+$240K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 51.58% |
| 2 | Healthcare | 17.23% |
| 3 | Materials | 8.1% |
| 4 | Energy | 7.63% |
| 5 | Technology | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nasdaq
NDAQ
$53.1B
| $6.34M | 0.55% |
100,500
| – | – |
|
27
Becton Dickinson
BDX
$49.4B
| $5.93M | 0.51% |
23,970
| – | – |
|
28
Fortive
FTV
$18.6B
| $5.72M | 0.49% |
88,246
| – | – |
|
29
Mastercard
MA
$492B
| $4.82M | 0.41% |
10,000
| – | – |
|
30
Veralto
VLTO
$23.9B
| $4.75M | 0.41% |
53,606
| – | – |
|
31
Boeing
BA
$184B
| $4.73M | 0.41% |
24,500
| – | – |
|
32
Lockheed Martin
LMT
$138B
| $3.34M | 0.29% |
7,340
| – | – |
|
33
Honeywell
HON
$72.9B
| $3.33M | 0.29% |
17,188
| – | – |
|
34
Jack Henry & Associates
JKHY
$10.9B
| $3.31M | 0.28% |
19,070
| – | – |
|
35
Berkshire Hathaway Class B
BRK.B
$1.11T
| $3.23M | 0.28% |
7,670
| – | – |
|
36
Ametek
AME
$58.8B
| $3.18M | 0.27% |
17,380
| – | – |
|
37
Merck
MRK
$322B
| $3M | 0.26% |
22,710
| – | – |
|
38
Coca-Cola
KO
$372B
| $2.96M | 0.25% |
48,400
| – | – |
|
39
Vontier
VNT
$4.61B
| $2.58M | 0.22% |
56,786
| – | – |
|
40
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $2.46M | 0.21% |
58,810
| – | – |
|
41
Vanguard Health Care ETF
VHT
$19B
| $2.36M | 0.2% |
8,740
| – | – |
|
42
Alphabet (Google) Class A
GOOGL
$4.2T
| $1.78M | 0.15% |
11,780
| – | – |
|
|
43
3M
MMM
$94.4B
| $1.67M | 0.14% |
22,473
+957
| +4% | +$79.3K |
|
|
44
Bristol-Myers Squibb
BMY
$130B
| $1.62M | 0.14% |
29,820
-7,460
| -20% | -$380K |
|
45
Parker-Hannifin
PH
$134B
| $1.58M | 0.14% |
2,840
| – | – |
|
46
Bank of America
BAC
$448B
| $1.53M | 0.13% |
40,240
| – | – |
|
47
Gilead Sciences
GILD
$168B
| $1.36M | 0.12% |
18,630
| – | – |
|
48
Union Pacific
UNP
$174B
| $1M | 0.09% |
4,080
| – | – |
|
49
Ecolab
ECL
$79.8B
| $857K | 0.07% |
3,710
| – | – |
|
50
MetLife
MET
$61.5B
| $784K | 0.07% |
10,580
| – | – |
|
Similar funds
QIM
NOCM
OAM
EPIMS
BCM
PCM
BOTOTLSJU
TSS
Hikari Power's Q1 2024 Portfolio in Review
As of Q1 2024, Hikari Power held 64 positions worth $1.16B, up 11% from $1.05B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 1.6%. Hikari Power opened no new positions and exited 1, leaving the 64-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Materials.
- Hikari Power added most to 3M in Q1 2024, an estimated $79.3K increase.
- Hikari Power's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $1.87M.
- Hikari Power fully exited Elevance Health in Q1 2024, selling an estimated $240K.
- Hikari Power's ten largest holdings make up 75% of its $1.16B portfolio in Q1 2024.
- Hikari Power opened 0 new positions and closed 1 in Q1 2024.
- Hikari Power's portfolio value rose 11% quarter-over-quarter to $1.16B.
Based on Hikari Power's 13F filing for Q1 2024, filed 8 May 2024.